血管内影像引导与冠状动脉造影引导经皮冠状动脉介入治疗的系统综述与Meta分析
该系统综述与Meta分析纳入20项随机对照试验(n=11698),比较血管内影像引导与冠状动脉造影引导的经皮冠状动脉介入治疗。血管内影像引导与心源性死亡、心肌梗死、支架血栓、靶血管血运重建和靶病变血运重建风险降低相关,但与全因死亡无显著相关。基于SYNTAX风险分类,绝对获益从低危到高危逐渐增大。
要点
- 血管内影像引导PCI与心源性死亡风险降低相关(率比0.53,95%CI 0.39-0.72)。
- 血管内影像引导PCI与心肌梗死、支架血栓、靶血管和靶病变血运重建风险降低相关。
- 全因死亡无显著差异(率比0.81,95%CI 0.64-1.02)。
核心结论
- 与冠状动脉造影引导的PCI相比,血管内影像引导的PCI与心源性死亡和心血管结局显著降低相关。
- 血管内影像引导PCI的估计绝对效应与基线风险成比例关系,由冠状动脉疾病的严重性和复杂性驱动。
研究设计与样本
- 系统综述与Meta分析,检索PubMed/Medline、Embase和Cochrane Library数据库至2023年8月31日。
- 纳入比较血管内影像(血管内超声或光学相干断层扫描)引导与冠状动脉造影引导的PCI的随机对照试验,共20项试验,n=11698。
- 采用随机效应Meta分析和GRADE评估证据确定性。
主要发现
- 血管内影像引导PCI与心源性死亡风险降低相关(率比0.53,95%CI 0.39-0.72)。
- 血管内影像引导PCI与心肌梗死风险降低相关(率比0.81,95%CI 0.68-0.97)。
- 血管内影像引导PCI与支架血栓风险降低相关(率比0.44,95%CI 0.27-0.72)。
- 血管内影像引导PCI与靶血管血运重建风险降低相关(率比0.74,95%CI 0.61-0.89),与靶病变血运重建风险降低相关(率比0.71,95%CI 0.59-0.86)。
- 全因死亡无显著差异(率比0.81,95%CI 0.64-1.02)。
关键数值与推荐
- 基于SYNTAX风险分类,高确定性证据显示从低危到高危,血管内影像引导每1000人减少心源性死亡23至64例。
- 基于SYNTAX风险分类,高确定性证据显示从低危到高危,血管内影像引导每1000人减少心肌梗死15至19例。
- 基于SYNTAX风险分类,高确定性证据显示从低危到高危,血管内影像引导每1000人减少支架血栓事件9至13例。
- 基于SYNTAX风险分类,高确定性证据显示从低危到高危,血管内影像引导每1000人减少靶血管血运重建事件28至38例。
- 基于SYNTAX风险分类,高确定性证据显示从低危到高危,血管内影像引导每1000人减少靶病变血运重建事件35至48例。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the absolute treatment effects of intravascular imaging guided versus angiography guided percutaneous coronary intervention in patients with coronary artery disease, considering their baseline risk. DESIGN: Systematic review and meta-analysis. DATA SOURCES: PubMed/Medline, Embase, and Cochrane Library databases up to 31 August 2023. STUDY SELECTION: Randomized controlled trials comparing intravascular imaging (intravascular ultrasonography or optical coherence tomography) guided versus coronary angiography guided percutaneous coronary intervention in adults with coronary artery disease. MAIN OUTCOME MEASURES: Random effect meta-analysis and GRADE (grading of recommendations, assessment, development, and evaluation) were used to assess certainty of evidence. Data included rate ratios and absolute risks per 1000 people for cardiac death, myocardial infarction, stent thrombosis, target vessel revascularization, and target lesion revascularization. Absolute risk differences were estimated using SYNTAX risk categories for baseline risks at five years, assuming constant rate ratios across different cardiovascular risk thresholds. RESULTS: In 20 randomized controlled trials (n=11 698), intravascular imaging guided percutaneous coronary intervention was associated with a reduced risk of cardiac death (rate ratio 0.53, 95% confidence interval 0.39 to 0.72), myocardial infarction (0.81, 0.68 to 0.97), stent thrombosis (0.44, 0.27 to 0.72), target vessel revascularization (0.74, 0.61 to 0.89), and target lesion revascularization (0.71, 0.59 to 0.86) but not all cause death (0.81, 0.64 to 1.02). Using SYNTAX risk categories, high certainty evidence showed that from low risk to high risk, intravascular imaging was likely associated with 23 to 64 fewer cardiac deaths, 15 to 19 fewer myocardial infarctions, 9 to 13 fewer stent thrombosis events, 28 to 38 fewer target vessel revascularization events, and 35 to 48 fewer target lesion revascularization events per 1000 people. CONCLUSIONS: Compared with coronary angiography guided percutaneous coronary intervention, intravascular imaging guided percutaneous coronary intervention was associated with significantly reduced cardiac death and cardiovascular outcomes in patients with coronary artery disease. The estimated absolute effects of intravascular imaging guided percutaneous coronary intervention showed a proportional relation with baseline risk, driven by the severity and complexity of coronary artery disease. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42023433568.
引用
- Khan SU, Agarwal S, Arshad HB, et al. Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis. BMJ. 2023. PMID: 37973170. doi:10.1136/bmj-2023-077848
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。